Fortress Biotech (FBIO) Net Cash Flow (2010 - 2025)

Fortress Biotech's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$6.8 million for Q4 2025.

• In Q4 2025, Net Cash Flow fell 225.42% year-over-year to -$6.8 million; the TTM figure through Dec 2025 stood at $21.8 million (up 188.74% YoY), while the FY2025 annual figure was $21.8 million, up 188.74% from the prior year.
• Net Cash Flow for Q4 2025 stood at -$6.8 million, down from $11.8 million in the prior quarter.
• The five-year high for Net Cash Flow was $56.5 million in Q1 2021, with the low at -$65.7 million in Q2 2023.
• The 5-year median for Net Cash Flow is -$14.7 million (2021), against an average of -$7.7 million.
• The sharpest annual moves came in 2021 and 2025: Net Cash Flow surged 6279.89% in 2021, then sank 225.42% in 2025.
• Fortress Biotech's Net Cash Flow stood at $53.6 million in 2021, then tumbled by 155.26% to -$29.6 million in 2022, then surged by 129.1% to $8.6 million in 2023, then plunged by 124.37% to -$2.1 million in 2024, then tumbled by 225.42% to -$6.8 million in 2025.
• Business Quant data shows FBIO's Net Cash Flow at -$6.8 million in Q4 2025, $11.8 million in Q3 2025, and -$17.0 million in Q2 2025.